DGAP-News: Epigenomics AG / Key word(s): Bond 2015-12-18 / 17:23 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Bondholders resolve on amendment of the terms and conditions of the 2013 Convertible Bonds: – Extension of the Term until December 31, 2016 – Amendment of the Anti-Dilution Protection Berlin […]
Year: 2015
18. December 2015
Epigenomics AG: Bondholders resolve on amendment of the terms and conditions of the 2013 Convertible Bonds
Read more
26. November 2015
DGAP-DD: Epigenomics AG deutsch
Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG Directors’-Dealings-Mitteilung übermittelt durch DGAP – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Mitteilungspflichtige verantwortlich. ————————————————————————— Angaben zum Mitteilungspflichtigen Name: von Prondzynski Vorname: Heino Firma: Epigenomics AG Funktion: Verwaltungs- oder Aufsichtsorgan Angaben zum mitteilungspflichtigen Geschäft Bezeichnung des Finanzinstruments: Aktie ISIN/WKN des Finanzinstruments: […]
25. November 2015
Epigenomics AG appeals recent FDA request for additional information
Epigenomics AG / Key word(s): Miscellaneous 25.11.2015 22:41 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act) Epigenomics AG […]
18. November 2015
Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG 18.11.2015 18:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 German Securities Trading Act – ‘WpHG’) in Accordance with § 26 para. […]
18. November 2015
Epigenomics AG Announces 2015 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights
DGAP-News: Epigenomics AG / Key word(s): 9-month figures 2015-11-18 / 07:30 Epigenomics AG Announces 2015 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights Berlin (Germany) and Germantown, MD (U.S.A.), November 18, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced its financial […]
09. November 2015
Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer
DGAP-News: Epigenomics AG / Key word(s): Study results/Conference 2015-11-09 / 08:30 Press release Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer Epigenomics’ DNA methylation biomarkers demonstrate high sensitivity compared to commonly used protein biomarkers Being developed as a blood-based test for early lung cancer detection […]